G-CSF Biosimilars Market Report

Global and Region G-CSF Biosimilars Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：222
  • REPORT CODE：GMM990591
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Granulocyte colony-stimulating factor (G-CSF) is a glycoprotein containing 174 amino acids with a molecular weight of about 20000.

    The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for G-CSF Biosimilars in US$ by the following Product Segments: Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating FactorCompany profiles are primarily based on public domain information including company Merck & Co.Gilead ScienceJohnson & JohnsonMerck & CoNovartisAmgenSanofiBayerRocheAstraZenecaGlaxoSmithKlinePfizer

    The report details the trend, potential and market size of G-CSF Biosimilars market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of G-CSF Biosimilarsmarket, defines the market attractiveness level of G-CSF Biosimilars market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of G-CSF Biosimilars industry, describes the types of G-CSF Biosimilars market, the applications of major players and the market size, and deeply analyzes the current situation of the global G-CSF Biosimilars market and the development prospects and opportunities of G-CSF Biosimilars industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global G-CSF Biosimilars market in Chapter 13.

    By Player:

    • AstraZeneca

    • GlaxoSmithKline

    • Pfizer

    • Johnson & Johnson

    • Gilead Science

    • AbbVie

    • Merck & Co

    • Novartis

    • Amgen

    • Sanofi

    • Bayer

    • Roche

    By Type:

    • Human Growth Hormone

    • Erythropoietin

    • Monoclonal Antibodies

    • Insulin

    • Interferon

    • Granulocyte-Colony Stimulating Factor

    By End-User:

    • Blood Disorders

    • Oncology Diseases

    • Chronic And Autoimmune Diseases

    • Growth Hormone Deficiencies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 G-CSF Biosimilars Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 G-CSF Biosimilars Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 G-CSF Biosimilars Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 G-CSF Biosimilars Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise G-CSF Biosimilars Market Analysis and Outlook to 2022

    • 7.1 Global G-CSF Biosimilars Consumption (2017-2022)

    • 7.2 United States G-CSF Biosimilars Consumption (2017-2022)

    • 7.3 Europe G-CSF Biosimilars Consumption (2017-2022)

    • 7.4 China G-CSF Biosimilars Consumption (2017-2022)

    • 7.5 Japan G-CSF Biosimilars Consumption (2017-2022)

    • 7.6 India G-CSF Biosimilars Consumption (2017-2022)

    • 7.7 South Korea G-CSF Biosimilars Consumption (2017-2022)

    8 Region and Country-wise G-CSF Biosimilars Market Analysis and Outlook to 2028

    • 8.1 Global G-CSF Biosimilars Consumption Forecast (2022-2028)

    • 8.2 United States G-CSF Biosimilars Consumption Forecast (2022-2028)

    • 8.3 Europe G-CSF Biosimilars Consumption Forecast (2022-2028)

    • 8.4 China G-CSF Biosimilars Consumption Forecast (2022-2028)

    • 8.5 Japan G-CSF Biosimilars Consumption Forecast (2022-2028)

    • 8.6 India G-CSF Biosimilars Consumption Forecast (2022-2028)

    • 8.7 South Korea G-CSF Biosimilars Consumption Forecast (2022-2028)

    9 Global G-CSF Biosimilars Market Outlook by Types and Applications to 2022

    • 9.1 Global G-CSF Biosimilars Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Human Growth Hormone Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Erythropoietin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Insulin Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Interferon Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Granulocyte-Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

    • 9.2 Global G-CSF Biosimilars Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Blood Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Oncology Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Chronic And Autoimmune Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Growth Hormone Deficiencies Consumption and Growth Rate (2017-2022)

    10 Global G-CSF Biosimilars Market Outlook by Types and Applications to 2028

    • 10.1 Global G-CSF Biosimilars Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Human Growth Hormone Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Insulin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Interferon Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Granulocyte-Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global G-CSF Biosimilars Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Oncology Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Chronic And Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Growth Hormone Deficiencies Consumption Forecast and Growth Rate (2022-2028)

    11 Global G-CSF Biosimilars Import and Export Analysis (Top 5 Countries)

    • 11.1 Global G-CSF Biosimilars Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global G-CSF Biosimilars Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 G-CSF Biosimilars Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global G-CSF Biosimilars Market Competitive Analysis

    • 14.1 AstraZeneca

      • 14.1.1 AstraZeneca Company Details

      • 14.1.2 AstraZeneca G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AstraZeneca G-CSF Biosimilars Product and Service

    • 14.2 GlaxoSmithKline

      • 14.2.1 GlaxoSmithKline Company Details

      • 14.2.2 GlaxoSmithKline G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 GlaxoSmithKline G-CSF Biosimilars Product and Service

    • 14.3 Pfizer

      • 14.3.1 Pfizer Company Details

      • 14.3.2 Pfizer G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Pfizer G-CSF Biosimilars Product and Service

    • 14.4 Johnson & Johnson

      • 14.4.1 Johnson & Johnson Company Details

      • 14.4.2 Johnson & Johnson G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Johnson & Johnson G-CSF Biosimilars Product and Service

    • 14.5 Gilead Science

      • 14.5.1 Gilead Science Company Details

      • 14.5.2 Gilead Science G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Gilead Science G-CSF Biosimilars Product and Service

    • 14.6 AbbVie

      • 14.6.1 AbbVie Company Details

      • 14.6.2 AbbVie G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AbbVie G-CSF Biosimilars Product and Service

    • 14.7 Merck & Co

      • 14.7.1 Merck & Co Company Details

      • 14.7.2 Merck & Co G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Merck & Co G-CSF Biosimilars Product and Service

    • 14.8 Novartis

      • 14.8.1 Novartis Company Details

      • 14.8.2 Novartis G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Novartis G-CSF Biosimilars Product and Service

    • 14.9 Amgen

      • 14.9.1 Amgen Company Details

      • 14.9.2 Amgen G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Amgen G-CSF Biosimilars Product and Service

    • 14.10 Sanofi

      • 14.10.1 Sanofi Company Details

      • 14.10.2 Sanofi G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Sanofi G-CSF Biosimilars Product and Service

    • 14.11 Bayer

      • 14.11.1 Bayer Company Details

      • 14.11.2 Bayer G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Bayer G-CSF Biosimilars Product and Service

    • 14.12 Roche

      • 14.12.1 Roche Company Details

      • 14.12.2 Roche G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Roche G-CSF Biosimilars Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of G-CSF Biosimilars

    • Figure G-CSF Biosimilars Picture

    • Table Global G-CSF Biosimilars Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global G-CSF Biosimilars Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global G-CSF Biosimilars Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global G-CSF Biosimilars Consumption by Country (2017-2022)

    • Figure United States G-CSF Biosimilars Consumption and Growth Rate (2017-2022)

    • Table Europe G-CSF Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure China G-CSF Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure Japan G-CSF Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure India G-CSF Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure South Korea G-CSF Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure Global G-CSF Biosimilars Consumption Forecast by Country (2022-2028)

    • Figure United States G-CSF Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe G-CSF Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure China G-CSF Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan G-CSF Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure India G-CSF Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea G-CSF Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Human Growth Hormone Consumption and Growth Rate (2017-2022)

    • Figure Global Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Insulin Consumption and Growth Rate (2017-2022)

    • Figure Global Interferon Consumption and Growth Rate (2017-2022)

    • Figure Global Granulocyte-Colony Stimulating Factor Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic And Autoimmune Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Growth Hormone Deficiencies Consumption and Growth Rate (2017-2022)

    • Figure Global Human Growth Hormone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Interferon Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Granulocyte-Colony Stimulating Factor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chronic And Autoimmune Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Growth Hormone Deficiencies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global G-CSF Biosimilars Import by Region (Top 5 Countries) (2017-2028)

    • Table Global G-CSF Biosimilars Export by Region (Top 5 Countries) (2017-2028)

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca G-CSF Biosimilars Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline G-CSF Biosimilars Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer G-CSF Biosimilars Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson G-CSF Biosimilars Product and Service

    • Table Gilead Science (Foundation Year, Company Profile and etc.)

    • Table Gilead Science G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Science G-CSF Biosimilars Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie G-CSF Biosimilars Product and Service

    • Table Merck & Co (Foundation Year, Company Profile and etc.)

    • Table Merck & Co G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co G-CSF Biosimilars Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis G-CSF Biosimilars Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen G-CSF Biosimilars Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi G-CSF Biosimilars Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer G-CSF Biosimilars Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche G-CSF Biosimilars Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche G-CSF Biosimilars Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US